NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
DR PHARMA DR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/02/2024
Trademark type
Combined
Nice classes
5, 35
Filing date
01/28/2022
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2023
First use in commerce
06/01/2023
Drawing code
5
Owner type
16
Owner location
BRITISH COLUMBIA, CA
Examiner
WHELAN, JAIME M
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
REAL ORGANICS & NATURALS HOUSE LTD.
Representatives
Nan Z. Carr NZ CARR LAW OFFICE, PLLC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplementsherbal supplementsnutritional supplements and vitamin supplements for general health and well-being
Class 35
Wholesale store servicesonline retail store services and retail store services featuring dietary supplementsherbal supplementsnutritional supplements and vitamin supplements for general health and well-being
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/30/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/29/2023
DOCK
ASSIGNED TO EXAMINER
11/21/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/25/2023
IUAF
USE AMENDMENT FILED
08/17/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/17/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2022
GNRT
NON-FINAL ACTION E-MAILED
03/24/2022
CNRT
NON-FINAL ACTION WRITTEN
03/24/2022
DOCK
ASSIGNED TO EXAMINER
03/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2022
NWAP
NEW APPLICATION ENTERED
02/01/2022
Continuous trademark protection
Get notified about every new filing that threatens DR PHARMA DR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.